We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Imvax

News List

Imvax Appoints Sean Hemingway Chief Operating Officer contractpharma
April 09, 2021
Imvax, Inc., a developer of immunotherapy for Glioblastoma (GBM) and other cancers, has appointed Sean Hemingway as Chief Operating Officer.
IGV-001 demonstrates success against glioblastoma in Phase Ib trial europeanpharmaceuticalreview
January 28, 2021
Imvax’s Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma has shown positive results.
Imvax Appoints Wendy DiCicco as New Board Member prnasia
September 17, 2020
Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, announced the appointment of Wendy DiCicco to its board of ...
Imvax Appoints Chief Scientific Officer contractpharma
April 24, 2020
Mark Exley brings experience in the regulation of the immune system to treat cancer and other diseases.